Clinical trial NBTXR3-301 Nanobiotix
A multicentre randomized, open-label Phase II/III study, to compare the efficacy of NBTXR3, implanted as intratumor injection and activated by radiotherapy, versus radiotherapy alone in patients with locally advanced soft tissue sarcoma of the extremity and trunk wall
| Cancers | |
|---|---|
| Organ | sarcome |
| Trial status | Trial closed |
| Trial type |
Medical devices
|
| Phase | Trial phase 2/3 |
| Academic trial | Non |
| Sponsor | Nanobiotix |
| EudraCT Identifier | CIV-FR-15-02-013179 |
| BECT Identifier | B079201629000 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02379845 |
| Inclusion criteria | Subject is able to receive radiotherapy and surgery |
| Last update |